Acridines As Inhibitors Of Haspin And DYRK Kinases
申请人:Higgins Jonathan
公开号:US20130102627A1
公开(公告)日:2013-04-25
The present disclosure is directed to compounds of Formula I: which are inhibitors of Haspin kinase and DYRK kinases. The compounds of the present disclosure, and compositions thereof, are useful in the treatment of disease related to Haspin kinase and DYRK kinase expression and/or activity.